Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

Abstract

Consensus guidelines were proposed based on global expert opinion and practical experience to bridge the gap between clinical needs and the absence of medical evidence, to guide the treatment of patients with NIU during the COVID-19 pandemic.